Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, and Virus-based gene therapy research.
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations
Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma